InVivoSIM anti-human amyloid beta (Donanemab Biosimilar)

货号 #SIM0048
克隆号:
Donanemab
反应种属:
Human

¥2,448 - ¥84,656

选择参数
  • 100 mg - ¥84,656
  • 50 mg - ¥47,568
  • 25 mg - ¥33,088
  • 5 mg - ¥9,472
  • 1 mg - ¥2,448
  • 定制包装(请询价)

产品详情

This non-therapeutic biosimilar antibody uses the same variable regions as the therapeutic antibody Donanemab, making it ideal for research use. Donanemab is a humanized IgG1κ anti-human APP antibody, and it specifically reacts with abeta 42 (Aβ42), a pyroglutamate form of Aβ that is aggregated in amyloid plaques during the pathogenesis of Alzheimer’s disease (AD). Aβ42 results from an aberrant processing of amyloid-β protein precursor (APP or AβPP). The initial cleavage of APP is caused by either α- secretase or β-secretase (or BACE1). sAPPα and the α-C-terminal fragment (α-CTF or APP-C83) are produced by α-secretase cleavage of APP, whereas sAPPβ and the β-C-terminal fragment (β-CTF or APP-C99) are produced by β-secretase cleavage. γ-secretase further cleaves C83 and C99, yielding the P3 peptide and Aβ, respectively. Depending on the location of the γ-secretase cleavage, Aβ can have a length of 37-43 amino acids in its peptide sequence. The two main Aβ species are Aβ42 and Aβ40. In early AD pathology, Aβ species play a critical role by seeding toxic oligomeric species with Aβ42 being more preferentially depositing in amyloid plaques than Aβ40. Donanemab specifically recognizes Aβ p3-42 (Aβ42) and it is reported to impede the progression of AD by clearing plaques through microglial-mediated phagocytosis in mice without causing microhemorrhages. Donanemab biosimilar antibodies are commonly used for in vitro and in vivo studies involving Alzheimer's disease and Down syndrome experimental models.

参数

同种型 Human IgG1, κ
推荐的同型对照 RecombiMAb human IgG1 isotype control, anti-hen egg lysozyme
推荐稀释缓冲液 InVivoPure pH 7.0 Dilution Buffer
免疫原 Human APP
Reported Applications in vivo functional assays in vitro functional assays ELISA Western blot
形式 PBS, pH 7.0 Contains no stabilizers or preservatives
内毒素 <0.5EU/mg (<0.0005EU/μg) Determined by LAL gel clotting assay
聚合 <5% Determined by SEC
纯化 >95% Determined by SDS-PAGE
无菌性 0.2 μM filtration
生产 Purified from cell culture supernatant in an animal-free facility
分子量 150 kDa
小鼠病原体试验 Mouse Norovirus: Negative Mouse Parvovirus: Negative Mouse Minute Virus: Negative Mouse Hepatitis Virus: Negative Reovirus Screen: Negative Lymphocytic Choriomeningitis virus: Negative Lactate Dehydrogenase-Elevating Virus: Negative Mouse Rotavirus: Negative Theiler's Murine Encephalomyelitis: Negative Ectromelia/Mousepox Virus: Negative Hantavirus: Negative Polyoma Virus: Negative Mouse Adenovirus: Negative Sendai Virus: Negative Mycoplasma Pulmonis: Negative Pneumonia Virus of Mice: Negative Mouse Cytomegalovirus: Negative K Virus: Negative
保存 The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
点击关闭